Oppenheimer & Co’s Medpace MEDP Stock Holding History

Oppenheimer & Co’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,177	Closed	-$361K	–	1485
2023 Q4	$361K	Buy	+1,177	New	+$318K	0.01%	1073
2023 Q2	–	Sell	-2,421	Closed	-$455K	–	1456
2023 Q1	$455K	Buy	+2,421	New	+$501K	0.01%	974

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Oppenheimer & Co's MEDP Position: Q1 2024 in Review

Oppenheimer & Co sold out of Medpace (MEDP) in Q1 2024, closing a stake of 1,177 shares — an estimated $361K sold.

Oppenheimer & Co first reported a position in MEDP in Q1 2023 and held it in 2 quarters. The position peaked at $455K in Q1 2023. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.

Oppenheimer & Co reported no remaining Medpace position as of Q1 2024 after selling out during the quarter.
Oppenheimer & Co sold 1,177 Medpace shares in Q1 2024, an estimated $361K.
Oppenheimer & Co first reported a position in Medpace in Q1 2023 and held it in 2 quarters.
Oppenheimer & Co's Medpace position peaked at $455K in Q1 2023.
597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.

Based on Oppenheimer & Co's 13F filing for Q1 2024, filed 7 May 2024.